See All Slides - tctmd.com

Slides

Presentation TCT 2025

Case 2:

Presenter: Adam B. Greenbaum

October 28, 2025

Presentation TCT 2025

State of the Art Medical Therapies for Microvascular Disease

Presenter: Noel Bairey-Merz

October 28, 2025

Presentation TCT 2025

Is There a Practical Solution for Emergency Consent in USA Shock RCTs?

Presenter: Graham Nichol

October 28, 2025

Presentation TCT 2025

TCT 1195: Outcomes of Transcatheter Tricuspid Valve Replacement in Patients with Multivalvular Disease: Insights from the TRISCEND II Trial

Presenter: Akhil Narang

October 28, 2025

Presentation TCT 2025

TCT 267: Cardiogenic Shock Outcomes in Coronary Artery Disease (1999-2023): A Longitudinal Study of Mortality and Disparities.

Presenter: Ahmed Bahnasy

October 28, 2025

Presentation TCT 2025

TCT 1052: Identifying High-Risk Pulmonary Embolism Patients Through Combined Hemodynamic and Thrombotic Assessment

Presenter: Marco G. Mennuni

October 28, 2025

Presentation TCT 2025

TCT 493: Tailored Antiplatelet Therapy in High-Risk Diabetic Patients Undergoing Complex Percutaneous Coronary Intervention: The Prespecified Analysis of TAILORED-CHIP Trial

Presenter: Seong-Bong Wee

October 28, 2025

Presentation TCT 2025

TCT 240: Integrated Assessment of Coronary Physiology and Plaque Vulnerability Following Resorption of Magnesium-Resorbable Scaffolds

Presenter: Stefano Galli

October 28, 2025

Presentation TCT 2025

TCT 850: The Continuous Saline Infusion Rate Required to Achieve Maximal Hyperaemia for Catheter-Based Measurements of Absolute Coronary Blood Flow and Microcirculatory Resistance in Severe Aortic Stenosis – The CORFLO-AS Validate Trial

Presenter: Harsh V. Thakkar

October 28, 2025

Presentation TCT 2025

TCT 1519: Jailed, but Unharmed: Navigating Bi-Caval TricValve Implantation in Tricuspid Regurgitation With Multiple Pre-Existing Leads: A Complex Case From the TRICAV I US Early Feasibility Study

Presenter: Brian K. Whisenant

October 28, 2025

Advertisement

Slides

Case 2:

State of the Art Medical Therapies for Microvascular Disease

Is There a Practical Solution for Emergency Consent in USA Shock RCTs?

TCT 1195: Outcomes of Transcatheter Tricuspid Valve Replacement in Patients with Multivalvular Disease: Insights from the TRISCEND II Trial

TCT 267: Cardiogenic Shock Outcomes in Coronary Artery Disease (1999-2023): A Longitudinal Study of Mortality and Disparities.

TCT 1052: Identifying High-Risk Pulmonary Embolism Patients Through Combined Hemodynamic and Thrombotic Assessment

TCT 493: Tailored Antiplatelet Therapy in High-Risk Diabetic Patients Undergoing Complex Percutaneous Coronary Intervention: The Prespecified Analysis of TAILORED-CHIP Trial

TCT 240: Integrated Assessment of Coronary Physiology and Plaque Vulnerability Following Resorption of Magnesium-Resorbable Scaffolds

TCT 850: The Continuous Saline Infusion Rate Required to Achieve Maximal Hyperaemia for Catheter-Based Measurements of Absolute Coronary Blood Flow and Microcirculatory Resistance in Severe Aortic Stenosis – The CORFLO-AS Validate Trial

TCT 1519: Jailed, but Unharmed: Navigating Bi-Caval TricValve Implantation in Tricuspid Regurgitation With Multiple Pre-Existing Leads: A Complex Case From the TRICAV I US Early Feasibility Study

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content